NCGC00024983-08

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

58 Suppliers, 38 USDMF, 9 CEP/COS, 7 JDMF, 4 EU WC, 7 KDMF, 19 NDC API, 18 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

254 Dossiers, 75 FDA Orange Book, 81 Europe, 17 Canada, 8 Australia, 32 South Africa, 41 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 30MG, TABLET, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 90MG, TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 26 BASF, 24 Roquette, 13 Microlex e.U, 12 Corel Pharma Chem, 11 Ideal Cures Pvt Ltd, 10 Seppic, 10 Sigachi Industries, 8 Gangwal Chemicals, 8 Gangwal Healthcare, 8 Actylis, 7 Nanjing Well Pharmaceutical, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 SPI Pharma, 6 Lonza Capsugel, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 DFE Pharma, 4 ACG Worldwide, 4 Kima Chemical, 3 Doshion Polyscience, 3 The Dow Chemical Company, 3 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 3 Finar, 2 Ulanqab Kema New Material, 2 Evonik, 2 Vasa Pharmachem, 2 Ingredion Pharma Solutions, 2 Qualicaps, 2 Nomisma Healthcare, 2 Rochem International Inc, 2 Pharmatrans-Sanaq, 2 Prachin Chemical, 2 Seqens, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 40 Controlled & Modified Release, 29 Direct Compression, 22 Film Formers & Plasticizers, 22 Granulation, 20 Parenteral, 20 Taste Masking, 20 Solubilizers, 19 Thickeners and Stabilizers, 16 Lubricants & Glidants, 16 Topical, 14 Co-Processed Excipients, 14 Disintegrants & Superdisintegrants, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

44 US Medicaid Prescriptions, 87 Finished Drug Prices

MARKET PLACE

18 APIs, 16 DOSSIERS // FDF

PATENTS

4 Health Canada Patents

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 3 USP Standards, 15 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 18 News

Information, Expiry & Status of Health Canada Patents covering NCGC00024983-08.

NCGC00024983-08

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

58 Suppliers

38 USDMF

9 CEP/COS

7 JDMF

4 EU WC

7 KDMF

19 NDC API

18 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

254 Dossiers

75 FDA Orange Book

81 Europe

17 Canada

8 Australia

32 South Africa

41 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 10MG

CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 30MG

TABLET, EXTENDED RELEASE;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 90MG

TABLET, EXTENDED RELEASE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

26 BASF

24 Roquette

13 Microlex e.U

12 Corel Pharma Chem

11 Ideal Cures Pvt Ltd

10 Seppic

10 Sigachi Industries

8 Gangwal Chemicals

8 Gangwal Healthcare

8 Actylis

7 Nanjing Well Pharmaceutical

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 SPI Pharma

6 Lonza Capsugel

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 DFE Pharma

4 ACG Worldwide

4 Kima Chemical

3 Doshion Polyscience

3 The Dow Chemical Company

3 DKSH

3 Boai NKY Pharmaceuticals Ltd

3 Finar

2 Ulanqab Kema New Material

2 Evonik

2 Vasa Pharmachem

2 Ingredion Pharma Solutions

2 Qualicaps

2 Nomisma Healthcare

2 Rochem International Inc

2 Pharmatrans-Sanaq

2 Prachin Chemical

2 Seqens

1 Zhejiang Huakang Pharmaceutical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Aeon Procare

1 Shijiazhuang Huaxu Pharmaceutical

1 Clariant

1 Shanghai Welltone Material Technology Co., Ltd

CAPSULE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 60MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 90MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons